Prevalence and type distribution of high-risk human papillomavirus infections among women in Wufeng County, China

Archives of Gynecology and Obstetrics

Volumn 286, Issue 3, 2012, Pages 695-699

  Zhang, Li ^a   Wang, Youyou ^a   Peng, Min ^a,b   She, Qian ^a,c   Xiang, Qunying ^d   Chen, Qing ^a   Liu, Zhong ^e   Zhang, Wei ^b   Tao, Ning ^f   Qiu, Lixin ^a,c   Wu, Xinxing ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Lingqiao Hospital of Shanghai   (China)

^d Women and Children Healthcare Centre of Wufeng   (China)

^e Shenzhen Grand Care Medical Instrument Company   (China)

^f WUHAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Genotypes; HPV infection; Screening

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; ASIA; CANCER MORTALITY; CHINA; CONTROLLED STUDY; DNA SCREENING; EDUCATION; FEMALE; FLUORESCENCE ANALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH SURVEY; HIGH RISK POPULATION; HPV 67; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

ADULT; CHINA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; VIRAL LOAD; YOUNG ADULT;

EID: 84867981922     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2344-0     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
3. zur Hausen H (2009) Papillomaviruses in the causation of human cancers-a brief historical account, 2009. Virology 384:260-265
4. zur Hausen H (1987) Papilloma virus in human cancer. Cancer 59:1692-1696
5. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, CliVord GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A metaanalysis update. Int J Cancer 121(3):621-632 (Pubitemid 46986496)
6. Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 30(24 Suppl 1):S1-S15
7. Sanjose S, Diaz M, Castellsague X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459 (Pubitemid 46962343)
8. Bao YP, Li N, Smith JS et al (2008) Human papillomavirus type distribution in women from Asia: A meta-analysis. Int J Gynecol Cancer 18(1):71-79
9. Lo KW, Wong YF, Chan MK et al (2002) Prevalence of human papillomavirus in cervical cancer: A multicenter study in China. Int J Cancer 100(3):327-331 (Pubitemid 34728991)
10. Muñoz N, Bosch FX, de Sanjosé S et al (2003) Epidemiologic classiWcation of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527 (Pubitemid 36159887)
11. Mandelblatt JS, Lawrence WF, GaYkin L et al (2002) Costs and beneWts of diVerent strategies to screen for cervical cancer in lessdeveloped countries. J Natl Cancer Inst 94:1469-1483 (Pubitemid 35243745)
12. Kim K, Zang R, Choi SC, Ryu SY, Kim JW (2009) Current status of gynecological cancer in China. J Gynecol Oncol 20:72-76
13. Youyou W, Qunying X, Qian S et al (2011) HPV infection and re lated factors among women in high cervical cancer incidence area. Chin J Public Health 27:259-261
14. Smith JS, Melendy A, Rana RK, Pimenta JM (2008) Age-speciWc prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 43:s5-25, Se1-41
15. Thomas JO, Herrero R, Omigbodun AA et al (2004) Prevalence of papillomavirus infection in women in Ibadan, Nigeria: A population-based study. Br J Cancer 90:638-645 (Pubitemid 38297204)
16. Kjaer SK, Chackerian B, van den Brule AJ et al (2001) High-risk human papillomavirus is sexually transmitted: Evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101-106 (Pubitemid 32172427)
17. Ozçelik B, Serin IS, Gökahmetoflu S et al (2003) Human papillomavirus frequency of women at low risk of developing cervical cancer: A preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol 24(2):157-159
18. Bao YP, Li N, Smith JS, Qiao YL (2008) Human papillomavirus type distribution in women from Asia: A meta-analysis. Int J Gynecol Cancer 18:71-79
19. CliVord GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73
20. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008) A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination. Vaccine 26:2811-2817